|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620.
2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qian L, Yu S, Chen Z, Meng Z, Huang S and
Wang P: Functions and clinical implications of exosomes in
pancreatic cancer. Biochim Biophys Acta Rev Cancer. 1871:75–84.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang L, Sanagapalli S and Stoita A:
Challenges in diagnosis of pancreatic cancer. World J
Gastroenterol. 24:2047–2060. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang J, Ren B, Yang G, Wang H, Chen G, You
L, Zhang T and Zhao Y: The enhancement of glycolysis regulates
pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rouanet M, Lebrin M, Gross F, Bournet B,
Cordelier P and Buscail L: Gene Therapy for Pancreatic Cancer:
Specificity, Issues and Hopes. Int J Mol Sci.
18(1231)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kurtanich T, Roos N, Wang G, Yang J, Wang
A and Chung EJ: Pancreatic Cancer Gene Therapy Delivered by
Nanoparticles. SLAS Technol. 24:151–160. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wu J, Li Z, Zeng K, Wu K, Xu D, Zhou J and
Xu L: Key genes associated with pancreatic cancer and their
association with outcomes: A bioinformatics analysis. Mol Med Rep.
20:1343–1352. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arnaud F, Black SG, Murphy L, Griffiths
DJ, Neil SJ, Spencer TE and Palmarini M: Interplay between ovine
bone marrow stromal cell antigen 2/tetherin and endogenous
retroviruses. J Virol. 84:4415–4425. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gong S, Osei ES, Kaplan D, Chen YH and
Meyerson H: CD317 is over-expressed in B-cell chronic lymphocytic
leukemia, but not B-cell acute lymphoblastic leukemia. Int J Clin
Exp Pathol. 8:1613–1621. 2015.PubMed/NCBI
|
|
14
|
Wang W, Nishioka Y, Ozaki S, Jalili A, Abe
S, Kakiuchi S, Kishuku M, Minakuchi K, Matsumoto T and Sone S:
HM1.24 (CD317) is a novel target against lung cancer for
immunotherapy using anti-HM1.24 antibody. Cancer Immunol
Immunother. 58:967–976. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Malsy M, Graf B and Almstedt K: The active
role of the transcription factor Sp1 in NFATc2-mediated gene
regulation in pancreatic cancer. BMC Biochem. 20(2)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Safe S, Nair V and Karki K:
Metformin-induced anticancer activities: Recent insights. Biol
Chem. 399:321–335. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nair V, Pathi S, Jutooru I, Sreevalsan S,
Basha R, Abdelrahim M, Samudio I and Safe S: Metformin inhibits
pancreatic cancer cell and tumor growth and downregulates Sp
transcription factors. Carcinogenesis. 34:2870–2879.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hogendorf P, Durczyński A and Strzelczyk
J: Metastatic Pancreatic Cancer. J Invest Surg. 31:151–152.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ferrone CR, Brennan MF, Gonen M, Coit DG,
Fong Y, Chung S, Tang L, Klimstra D and Allen PJ: Pancreatic
adenocarcinoma: The actual 5-year survivors. J Gastrointest Surg.
12:701–706. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hackert T, Klaiber U, Pausch T, Mihaljevic
AL and Büchler MW: Fifty Years of Surgery for Pancreatic Cancer.
Pancreas. 49:1005–1013. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Das S and Batra SK: Pancreatic cancer
metastasis: Are we being pre-EMTed? Curr Pharm Des. 21:1249–1255.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ishikawa J, Kaisho T, Tomizawa H, Lee BO,
Kobune Y, Inazawa J, Oritani K, Itoh M, Ochi T, Ishihara K, et al:
Molecular cloning and chromosomal mapping of a bone marrow stromal
cell surface gene, BST2, that may be involved in pre-B-cell growth.
Genomics. 26:527–534. 1995.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fujiwara K, Ohuchida K, Sada M, Horioka K,
Ulrich CD III, Shindo K, Ohtsuka T, Takahata S, Mizumoto K, Oda Y,
et al: CD166/ALCAM expression is characteristic of tumorigenicity
and invasive and migratory activities of pancreatic cancer cells.
PLoS One. 9(e107247)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xu X, Wang Y, Xue F, Guan E, Tian F, Xu J
and Zhang H: BST2 Promotes Tumor Growth via Multiple Pathways in
Hepatocellular Carcinoma. Cancer Invest. 38:329–337.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu W, Li Y, Feng S, Guan Y and Cao Y:
MicroRNA-760 inhibits cell viability and migration through
down-regulating BST2 in gastric cancer. J Biochem. 168:159–170.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu W, Cao Y, Guan Y and Zheng C: BST2
promotes cell proliferation, migration and induces NF-κB activation
in gastric cancer. Biotechnol Lett. 40:1015–1027. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang X, Zhuang H, Han F, Shao X, Liu Y,
Ma X, Wang Z, Qiang Z and Li Y: Sp1-regulated transcription of
RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
Liver Int. 38:2006–2017. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Peng X, Wu M, Liu W, Guo C, Zhan L and
Zhan X: miR-502-5p inhibits the proliferation, migration and
invasion of gastric cancer cells by targeting SP1. Oncol Lett.
20:2757–2762. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xue L, Shen Y, Zhai Z and Zheng S: miR 539
suppresses the proliferation, migration, invasion and epithelial
mesenchymal transition of pancreatic cancer cells through targeting
SP1. Int J Mol Med. 45:1771–1782. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mi LD, Sun CX, He SW and Du GY:
SP1-Induced Upregulation of lncRNA LINC00514 Promotes Tumor
Proliferation and Metastasis in Osteosarcoma by Regulating miR-708.
Cancer Manag Res. 12:3311–3322. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bai Z, Wu Y, Bai S, Yan Y, Kang H, Ma W,
Zhang J, Gao Y, Hui B, Ma H, et al: Long non-coding RNA SNGH7 Is
activated by SP1 and exerts oncogenic properties by interacting
with EZH2 in ovarian cancer. J Cell Mol Med. 24:7479–7489.
2020.PubMed/NCBI View Article : Google Scholar
|
